Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the Dornier Urowave in patients with symptomatic benign prostatic hyperplasia

Symptomatic Benign Prostatic Hyperplasia

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Urology ◽

10.1016/j.urology.2019.02.030 ◽

2019 ◽

Vol 129 ◽

pp. 172-179 ◽

Cited By ~ 3

Author(s):

Zhangqun Ye ◽

Jian Huang ◽

Liqun Zhou ◽

Shan Chen ◽

Zengjun Wang ◽

...

Keyword(s):

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Serenoa Repens ◽

Double Blind ◽

Double Blind Placebo

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

10.1016/j.juro.2012.11.003 ◽

2013 ◽

Vol 189 (4) ◽

pp. 1421-1426 ◽

Cited By ~ 39

Author(s):

Mostafa M. Elhilali ◽

Peter Pommerville ◽

Richard C. Yocum ◽

Rosemina Merchant ◽

Claus G. Roehrborn ◽

...

Keyword(s):

Clinical Trial ◽

Prostatic Hyperplasia ◽

Targeted Treatment ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Multicenter Phase

Randomized Double Blind Study Comparing the Effectiveness of Balloon Dilation of the Prostate and Cystoscopy for the Treatment of Symptomatic Benign Prostatic Hyperplasia

10.1016/s0022-5347(17)37331-7 ◽

1992 ◽

Vol 147 (3 Part 1) ◽

pp. 639-642 ◽

Cited By ~ 64

Author(s):

Herbert Lepor ◽

Dirk Sypherd ◽

Grace Machi ◽

Jeffrey Derus

Keyword(s):

Symptomatic Benign Prostatic Hyperplasia

Balloon Dilation ◽

Prostatic Hyperplasia ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial

Arab Journal of Urology ◽

10.1016/j.aju.2016.11.001 ◽

2017 ◽

Vol 15 (1) ◽

pp. 53-59 ◽

Cited By ~ 10

Author(s):

Amr Fawzi ◽

Mostafa Kamel ◽

Emad Salem ◽

Esam Desoky ◽

Mohamed Omran ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Lower Urinary

PD22-12 EFFICACY OF DOSE ESCALATION OF TAMSULOSIN FOR THE TREATMENT IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA OF LOWER URINARY TRACT SYMPTOMS: A RANDOMISED, DOUBLE-BLIND, PHASE 3 TRIAL IN KOREAN MEN.

10.1016/j.juro.2016.02.1505 ◽

2016 ◽

Vol 195 (4S) ◽

Cited By ~ 2

Author(s):

Kyu Shik Kim ◽

Jae Heon Kim ◽

Seung Hwan Lee ◽

U-Syn Ha ◽

Deok Hyun Han ◽

...

Keyword(s):

Urinary Tract ◽

Dose Escalation ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Phase 3 ◽

Double Blind ◽

Symptomatic Benign Prostatic Hyperplasia ◽

Urinary Tract Symptoms ◽

Lower Urinary

Faculty Opinions recommendation of WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732542718.793554114 ◽

2018 ◽

Author(s):

Mitchell Humphreys

Keyword(s):

Randomized Controlled Trial ◽

Transurethral Resection ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Randomized Controlled

Intraprostatic botulinum toxin type “A” injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation

Neurourology and Urodynamics ◽

10.1002/nau.23390 ◽

2017 ◽

Vol 37 (3) ◽

pp. 1031-1038 ◽

Cited By ~ 4

Author(s):

Angelo Totaro ◽

Francesco Pinto ◽

Dario Pugliese ◽

Matteo Vittori ◽

Marco Racioppi ◽

...

Keyword(s):

Botulinum Toxin ◽

Medical Therapy ◽

Controlled Trial ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Urodynamic Evaluation

Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial

Urology ◽

10.1016/j.urology.2011.11.040 ◽

2012 ◽

Vol 79 (4) ◽

pp. 875-882 ◽

Cited By ~ 14

Author(s):

Evan Goldfischer ◽

John J. Kowalczyk ◽

William R. Clark ◽

Erin Brady ◽

Michael Anne Shane ◽

...

Keyword(s):

Controlled Trial ◽

Signs And Symptoms ◽

Prostatic Hyperplasia ◽

Hemodynamic Effects ◽

Double Blind ◽

Antagonist Therapy ◽

Once Daily ◽

Double Blind Placebo ◽

Adrenergic Antagonist

Re: Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial

10.1016/j.juro.2015.02.052 ◽

2015 ◽

Vol 193 (5) ◽

pp. 1592-1594

Author(s):

Steven A. Kaplan

Keyword(s):

Blood Flow ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Lower Urinary

Comparison of Murraya koenigii– and Tribulus terrestris–Based Oral Formulation Versus Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Men Aged >50 Years: A Double-Blind, Double-Dummy, Randomized Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.11.005 ◽

2011 ◽

Vol 33 (12) ◽

pp. 1943-1952 ◽

Cited By ~ 6

Author(s):

Gairik Sengupta ◽

Avijit Hazra ◽

Anup Kundu ◽

Anirban Ghosh

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Oral Formulation ◽

Prostatic Hyperplasia ◽

Tribulus Terrestris ◽

Murraya Koenigii ◽

Double Blind ◽

Randomized Controlled